These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 37349645)

  • 21. SOX2/SALL4 stemness axis modulates Notch signaling genes to maintain self-renewal capacity of esophageal squamous cell carcinoma.
    Forghanifard MM; Kasebi P; Abbaszadegan MR
    Mol Cell Biochem; 2021 Feb; 476(2):921-929. PubMed ID: 33098486
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SOX2 antagonizes WWC1 to drive YAP1 activation in esophageal squamous cell carcinoma.
    Chai Y; Li Q; Zhao H; Zhang Z; Yu X; Pang L; Liu Z; Zhao J; Wang L; Li F
    Cancer Med; 2019 Nov; 8(16):7055-7064. PubMed ID: 31560173
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of PTK6, via RNA sequencing analysis, as a suppressor of esophageal squamous cell carcinoma.
    Ma S; Bao JYJ; Kwan PS; Chan YP; Tong CM; Fu L; Zhang N; Tong AHY; Qin YR; Tsao SW; Chan KW; Lok S; Guan XY
    Gastroenterology; 2012 Sep; 143(3):675-686.e12. PubMed ID: 22705009
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SOX2 Promotes the Epithelial to Mesenchymal Transition of Esophageal Squamous Cells by Modulating Slug Expression through the Activation of STAT3/HIF-α Signaling.
    Gao H; Teng C; Huang W; Peng J; Wang C
    Int J Mol Sci; 2015 Sep; 16(9):21643-57. PubMed ID: 26370982
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comprehensive Exploration to Identify Predictive DNA Markers of ΔNp63/SOX2 in Drug Resistance in Human Esophageal Squamous Cell Carcinoma.
    Ooizumi Y; Kojima K; Igarashi K; Tanaka Y; Harada H; Yokota K; Kaida T; Ishii S; Tanaka T; Yokoi K; Nishizawa N; Washio M; Ushiku H; Katoh H; Kosaka Y; Mieno H; Hosoda K; Watanabe M; Katada C; Hiki N; Yamashita K
    Ann Surg Oncol; 2019 Dec; 26(13):4814-4825. PubMed ID: 31529309
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of Hippo/YAP signaling and Esophageal Squamous Carcinoma progression by an E3 ubiquitin ligase PARK2.
    Zhou X; Li Y; Wang W; Wang S; Hou J; Zhang A; Lv B; Gao C; Yan Z; Pang D; Lu K; Ahmad NH; Wang L; Zhu J; Zhang L; Zhuang T; Li X
    Theranostics; 2020; 10(21):9443-9457. PubMed ID: 32863938
    [No Abstract]   [Full Text] [Related]  

  • 27. TAB182 aggravates progression of esophageal squamous cell carcinoma by enhancing β-catenin nuclear translocation through FHL2 dependent manner.
    Gao A; Su Z; Shang Z; He C; Miao D; Li X; Zou S; Ding W; Zhou Y; Sun M; Zhou J
    Cell Death Dis; 2022 Oct; 13(10):900. PubMed ID: 36289198
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Two novel splice variants of SOX2OT, SOX2OT-S1, and SOX2OT-S2 are coupregulated with SOX2 and OCT4 in esophageal squamous cell carcinoma.
    Shahryari A; Rafiee MR; Fouani Y; Oliae NA; Samaei NM; Shafiee M; Semnani S; Vasei M; Mowla SJ
    Stem Cells; 2014 Jan; 32(1):126-34. PubMed ID: 24105929
    [TBL] [Abstract][Full Text] [Related]  

  • 29. AKT drives SOX2 overexpression and cancer cell stemness in esophageal cancer by protecting SOX2 from UBR5-mediated degradation.
    Wang Z; Kang L; Zhang H; Huang Y; Fang L; Li M; Brown PJ; Arrowsmith CH; Li J; Wong J
    Oncogene; 2019 Jun; 38(26):5250-5264. PubMed ID: 30894683
    [TBL] [Abstract][Full Text] [Related]  

  • 30. BRCA1-Associated Protein Increases Invasiveness of Esophageal Squamous Cell Carcinoma.
    Zhao Y; Wei L; Shao M; Huang X; Chang J; Zheng J; Chu J; Cui Q; Peng L; Luo Y; Tan W; Tan W; Lin D; Wu C
    Gastroenterology; 2017 Nov; 153(5):1304-1319.e5. PubMed ID: 28780075
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long non‑coding RNA MEG3 suppresses epithelial‑to‑mesenchymal transition by inhibiting the PSAT1‑dependent GSK‑3β/Snail signaling pathway in esophageal squamous cell carcinoma.
    Li MK; Liu LX; Zhang WY; Zhan HL; Chen RP; Feng JL; Wu LF
    Oncol Rep; 2020 Nov; 44(5):2130-2142. PubMed ID: 32901893
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stemness state regulators SALL4 and SOX2 are involved in progression and invasiveness of esophageal squamous cell carcinoma.
    Forghanifard MM; Ardalan Khales S; Javdani-Mallak A; Rad A; Farshchian M; Abbaszadegan MR
    Med Oncol; 2014 Apr; 31(4):922. PubMed ID: 24659265
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The PSMD14 inhibitor Thiolutin as a novel therapeutic approach for esophageal squamous cell carcinoma through facilitating SNAIL degradation.
    Jing C; Li X; Zhou M; Zhang S; Lai Q; Liu D; Ye B; Li L; Wu Y; Li H; Yue K; Chen P; Yao X; Wu Y; Duan Y; Wang X
    Theranostics; 2021; 11(12):5847-5862. PubMed ID: 33897885
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predicting the molecular role of MEIS1 in esophageal squamous cell carcinoma.
    Rad A; Farshchian M; Forghanifard MM; Matin MM; Bahrami AR; Geerts D; A'rabi A; Memar B; Abbaszadegan MR
    Tumour Biol; 2016 Feb; 37(2):1715-25. PubMed ID: 26314854
    [TBL] [Abstract][Full Text] [Related]  

  • 35. EIF3H promotes aggressiveness of esophageal squamous cell carcinoma by modulating Snail stability.
    Guo X; Zhu R; Luo A; Zhou H; Ding F; Yang H; Liu Z
    J Exp Clin Cancer Res; 2020 Aug; 39(1):175. PubMed ID: 32867821
    [TBL] [Abstract][Full Text] [Related]  

  • 36. microRNA-377 acts as a suppressor in esophageal squamous cell carcinoma through CBX3-dependent P53/P21 pathway.
    He Z; Chen J; Chen X; Wang H; Tang L; Han C
    J Cell Physiol; 2021 Jan; 236(1):107-120. PubMed ID: 33459391
    [TBL] [Abstract][Full Text] [Related]  

  • 37. RNF113A promotes the proliferation, migration and invasion, and is associated with a poor prognosis of esophageal squamous cell carcinoma.
    Wang L; Hou Z; Hasim A; Abuduerheman A; Zhang H; Niyaz M; Awut I; Upur H; Sheyhidin I
    Int J Oncol; 2018 Mar; 52(3):861-871. PubMed ID: 29393393
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SOX2 inhibits LLGL2 polarity protein in esophageal squamous cell carcinoma via miRNA-142-3p.
    Zhang S; Chen Y; Hu Q; Zhao T; Wang Z; Zhou Y; Wei Y; Zhao H; Wang J; Yang Y; Zhang J; Shi S; Zhang Y; Yang L; Fu Z; Liu K
    Cancer Biol Ther; 2022 Dec; 23(1):1-15. PubMed ID: 36131361
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Overexpression of OTX1 promotes tumorigenesis in patients with esophageal squamous cell carcinoma.
    Chai J; Xu T; Yang Y; Yuan Y; Xu J; Liu J; Wang K; Lv Y; Chai J; Kang Y; Chen L; Qin J; Jia Q; Li M
    Pathol Res Pract; 2022 Apr; 232():153841. PubMed ID: 35303522
    [TBL] [Abstract][Full Text] [Related]  

  • 40. L1CAM drives oncogenicity in esophageal squamous cell carcinoma by stimulation of ezrin transcription.
    Guo JC; Xie YM; Ran LQ; Cao HH; Sun C; Wu JY; Wu ZY; Liao LD; Zhao WJ; Fang WK; Li EM; Xu LY; Schachner M; Xie JJ
    J Mol Med (Berl); 2017 Dec; 95(12):1355-1368. PubMed ID: 28939985
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.